Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort

By afschroeder • August 22, 2025

Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J; CRIC Study Investigators. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort. JACC Adv. 2025 Aug 19;4(9):102068. doi: 10.1016/j.jacadv.2025.102068. Epub ahead of print. PMID: 40839904.

Tags: Aspirin, Cardiology/Epi, cardiovascular diseases, Chronic kidney disease, Harbor UCLA, lipoprotein(a), Publications

Spinal nociceptive denervation impedes subsequent chronic autonomic remodeling after myocardial infarction in male swine

van Weperen VYH, Hoang JD, Jani NR, Avasthi S, Chan CA, Cao K, Lokhandwala ZA, Emamimeybodi M, Atmani K, Vaseghi M. Spinal nociceptive denervation impedes[...]

Closed-loop bioelectronic block of stellate ganglia reduces neurotransmitter release and improves recovery following programmed ventricular pacing

Bender SA, Aladham R, Chan SA, Defelice L, Kang A, Mikhail K, Haridas S, Ardell JL, Shivkumar K, Ajijola OA, Smith CB, Vrabec TL. Closed-loop[...]

FAP-Directed CAR-NKT Cells for Multi-Target Suppression of Atherosclerotic Progression

Zhu E, Li YR, Cho J, Kropp R, Zhang Y, Sanaiha Y, Kwon OJ, Zhu Y, Park SK, Arianpour B, Justo M, Zhao P, Wang[...]